PD-Rx Pharmaceuticals, Inc.

Form 483FOIA Uncovered

Oklahoma City, Oklahoma, United StatesFEI 1641825Issued November 10, 2022

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 1641825.

Observations5

Issue DateNovember 10, 2022

StatusNo Warning Letter

Related Inspections4

Establishment Details

Firm: PD-Rx Pharmaceuticals, Inc.
Location: Oklahoma City, Oklahoma, United States
FEI Number: 1641825
Product Type: Drugs
Issue Date: November 10, 2022
Country: United States

Inspection History, 2009 to 2026

NAI1

VAI3

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

PD-Rx Pharmaceuticals, Inc. FDA Form 483, Oklahoma City, Oklahoma, November 10, 2022